Zhengye Biotechnology Holding (ZYBT) Accumulated Expenses (2024)
Zhengye Biotechnology Holding (ZYBT) has disclosed Accumulated Expenses for 1 consecutive years, with $357923.6 as the latest value for Q4 2024.
- Quarterly Accumulated Expenses changed N/A to $357923.6 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $357923.6 through Dec 2024, changed N/A year-over-year, with the annual reading at $352000.0 for FY2024, N/A changed from the prior year.
- Accumulated Expenses for Q4 2024 was $357923.6 at Zhengye Biotechnology Holding.
- The five-year high for Accumulated Expenses was $357923.6 in Q4 2024, with the low at $357923.6 in Q4 2024.